Morgan Stanley upgraded Alvotech (ALVO) to Overweight from Equal Weight with a $14 price target The firm says the company’s “consistent” research and commercial progress provide visibility on its outlook and validation of its operating model. Alvotech’s “breadth” of commercial partners across geographies is a value driver for the shares, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALVO: